Matches in SemOpenAlex for { <https://semopenalex.org/work/W4248222110> ?p ?o ?g. }
- W4248222110 abstract "Atrial fibrillation (AF) is the most frequent sustained arrhythmia. AF recurs frequently after restoration of normal sinus rhythm. Antiarrhythmic drugs have been widely used to prevent recurrence, but the effect of these drugs on mortality and other clinical outcomes is unclear.To determine, in patients who recovered sinus rhythm after AF, the effect of long-term treatment with antiarrhythmic drugs on death, stroke and embolism, adverse effects, pro-arrhythmia, and recurrence of AF.We updated the searches of CENTRAL on The Cochrane Libary (Issue 1 of 4, 2010), MEDLINE (1950 to February 2010) and EMBASE (1966 to February 2010). The reference lists of retrieved articles, recent reviews and meta-analyses were checked.Two independent reviewers selected randomised controlled trials comparing any antiarrhythmic with a control (no treatment, placebo or drugs for rate control) or with another antiarrhythmic, in adults who had AF and in whom sinus rhythm was restored. Post-operative AF was excluded.Two reviewers independently assessed quality and extracted data. Studies were pooled, if appropriate, using Peto odds ratio (OR). All results were calculated at one year of follow-up.In this update, 11 new studies met inclusion criteria, making a total of 56 included studies, comprising 20,771 patients. Compared with controls, class IA drugs quinidine and disopyramide (OR 2.39, 95% confidence interval (95%CI) 1.03 to 5.59, number needed to harm (NNH) 109, 95%CI 34 to 4985) and sotalol (OR 2.47, 95%CI 1.2 to 5.05, NNH 166, 95%CI 61 to 1159) were associated with increased all-cause mortality. Other antiarrhythmics did not seem to modify mortality.Several class IA (disopyramide, quinidine), IC (flecainide, propafenone) and III (amiodarone, dofetilide, dronedarone, sotalol) drugs significantly reduced recurrence of AF (OR 0.19 to 0.70, number needed to treat (NNT) 3 to 16). Beta-blockers (metoprolol) also reduced significantly AF recurrence (OR 0.62, 95% CI 0.44 to 0.88, NNT 9).All analysed drugs increased withdrawals due to adverse affects and all but amiodarone, dronedarone and propafenone increased pro-arrhythmia. We could not analyse other outcomes because few original studies reported them.Several class IA, IC and III drugs, as well as class II (beta-blockers), are moderately effective in maintaining sinus rhythm after conversion of atrial fibrillation. However, they increase adverse events, including pro-arrhythmia, and some of them (disopyramide, quinidine and sotalol) may increase mortality. Possible benefits on clinically relevant outcomes (stroke, embolisms, heart failure) remain to be established." @default.
- W4248222110 created "2022-05-12" @default.
- W4248222110 creator A5025973794 @default.
- W4248222110 creator A5054726027 @default.
- W4248222110 creator A5060316910 @default.
- W4248222110 creator A5072120776 @default.
- W4248222110 date "2012-05-16" @default.
- W4248222110 modified "2023-10-14" @default.
- W4248222110 title "Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation" @default.
- W4248222110 cites W123464713 @default.
- W4248222110 cites W126216541 @default.
- W4248222110 cites W13794257 @default.
- W4248222110 cites W1430322293 @default.
- W4248222110 cites W1515584008 @default.
- W4248222110 cites W1519386588 @default.
- W4248222110 cites W152522376 @default.
- W4248222110 cites W1635563422 @default.
- W4248222110 cites W1841210729 @default.
- W4248222110 cites W1929476630 @default.
- W4248222110 cites W1952704118 @default.
- W4248222110 cites W1964340152 @default.
- W4248222110 cites W1967775446 @default.
- W4248222110 cites W1969091562 @default.
- W4248222110 cites W1971505725 @default.
- W4248222110 cites W1972129938 @default.
- W4248222110 cites W1973215845 @default.
- W4248222110 cites W1975655911 @default.
- W4248222110 cites W1977757208 @default.
- W4248222110 cites W1979580255 @default.
- W4248222110 cites W1980277885 @default.
- W4248222110 cites W1980398647 @default.
- W4248222110 cites W1981070043 @default.
- W4248222110 cites W1981075801 @default.
- W4248222110 cites W1986868017 @default.
- W4248222110 cites W1987433022 @default.
- W4248222110 cites W1987576284 @default.
- W4248222110 cites W1987773120 @default.
- W4248222110 cites W1993832525 @default.
- W4248222110 cites W1994231358 @default.
- W4248222110 cites W1994595926 @default.
- W4248222110 cites W1998514870 @default.
- W4248222110 cites W1999651496 @default.
- W4248222110 cites W2002374666 @default.
- W4248222110 cites W2002745869 @default.
- W4248222110 cites W2005837250 @default.
- W4248222110 cites W2006116430 @default.
- W4248222110 cites W2006420438 @default.
- W4248222110 cites W2010386758 @default.
- W4248222110 cites W2010627883 @default.
- W4248222110 cites W2012872595 @default.
- W4248222110 cites W2014173051 @default.
- W4248222110 cites W2017833531 @default.
- W4248222110 cites W2019116262 @default.
- W4248222110 cites W2020084015 @default.
- W4248222110 cites W2020372143 @default.
- W4248222110 cites W2020509502 @default.
- W4248222110 cites W2022860271 @default.
- W4248222110 cites W2023778178 @default.
- W4248222110 cites W2023813919 @default.
- W4248222110 cites W2025506219 @default.
- W4248222110 cites W2026137049 @default.
- W4248222110 cites W2029191989 @default.
- W4248222110 cites W2029583033 @default.
- W4248222110 cites W2033449081 @default.
- W4248222110 cites W2034320670 @default.
- W4248222110 cites W2036556580 @default.
- W4248222110 cites W2037142997 @default.
- W4248222110 cites W2038390102 @default.
- W4248222110 cites W2040051636 @default.
- W4248222110 cites W2041743622 @default.
- W4248222110 cites W2042042566 @default.
- W4248222110 cites W2045783302 @default.
- W4248222110 cites W2047430853 @default.
- W4248222110 cites W2047496300 @default.
- W4248222110 cites W2050641928 @default.
- W4248222110 cites W2053623462 @default.
- W4248222110 cites W2056473894 @default.
- W4248222110 cites W2057893780 @default.
- W4248222110 cites W2058755860 @default.
- W4248222110 cites W2063659045 @default.
- W4248222110 cites W2065795116 @default.
- W4248222110 cites W2067293168 @default.
- W4248222110 cites W2067459975 @default.
- W4248222110 cites W2068427115 @default.
- W4248222110 cites W2068759328 @default.
- W4248222110 cites W2069360795 @default.
- W4248222110 cites W2069857567 @default.
- W4248222110 cites W2070145752 @default.
- W4248222110 cites W2072959339 @default.
- W4248222110 cites W2073525095 @default.
- W4248222110 cites W2073736344 @default.
- W4248222110 cites W2076828944 @default.
- W4248222110 cites W2078357889 @default.
- W4248222110 cites W2079582847 @default.
- W4248222110 cites W2087685091 @default.
- W4248222110 cites W2089824890 @default.
- W4248222110 cites W2089951092 @default.
- W4248222110 cites W2090208107 @default.
- W4248222110 cites W2096746249 @default.
- W4248222110 cites W2098722007 @default.